Breast Cancer

Cancer often brings with it bad news, including expensive bills, but one day, a surprise came – one I’ll never forget.

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

Cancer brought me a forced transformation and gave me better a perspective on life.

When my wife was going through breast cancer treatment, I started drawing with my non-dominant hand as a means of distraction and self-care.

After meeting a woman who was forced to wait five months between finding a lump and being diagnosed with breast cancer, I wondered if that time affected the stage of her disease.

The hold has been placed due to visual side effects in a number of patients with solid tumors.

Orserdu demonstrated improved outcomes and quality of life for certain patients with metastatic breast cancer.

I’m working through one of the toughest times of my life. Perserverance is one of the many things that cancer has taught me.

The FDA approval of Trodelvy for patients with HR-positive, HER2-negative metastatic breast cancer provides patients with another treatment option after hormone therapy and standard chemotherapy.

After I was diagnosed with stage 4 breast cancer, clinicians told me I wouldn’t make it to my 35th birthday, but I recently did — and look forward to celebrating many more.

The use of PD-L1 to predict outcomes highlights a possible opportunity to better understand which patients with ER-positive breast cancer may benefit from an immune checkpoint inhibitor.

I don’t think of nature as a distraction to my cancer, masking the symptoms or the reality of my disease, but rather as a therapy that offers comfort and serenity with no negative side effects.

As a health care provider who specializes in lymphedema, I had a unique perspective when I was diagnosed with cancer.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.

As a part of its “Speaking Out” video series, CURE® spoke with genetic counselor, Angela Trepanier, on behalf of FORCE, to grasp a better understanding of what genetic breast cancer is and what it means for patients and their families.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs about the importance of support for those affected by hereditary cancers.

As a part of its “Speaking Out” video series, CURE® spoke with genetic counselor, Angela Trepanier, on behalf of FORCE, about disparities seen in genetic testing for caner.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs, about how advocacy partnerships can bring greater awareness and education to patients with cancer and their families.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs, about clinical trials for patients with hereditary cancers and those who have a risk of developing.

Guidelines often use a cutoff of 70 years old for breast cancer treatment, but patients should discuss goals of care with their team to further personalize their care.

The new year brings reflection on living fully with cancer.

Reflecting on World Cancer Day got me thinking about butterflies, a symbol of hope, but, according to the “Butterfly Effect” theory, a small flap of their wings could have major impacts on the world, which is not very different from cancer.

The Food and Drug Administration approved Trodelvy for patients with pretreated, unresectable HR-positive, HER2-negative metastatic breast cancer.

Patients with breast cancer who lived in Southern states with Medicaid expansion were less likely to be diagnosed with metastatic disease and more likely to receive treatment.

While cancer is a horrible disease, it taught me some valuable lessons.

The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

I always viewed my doctors as being unapproachable on a personal level. I thought they were there to examine and diagnose me, imparting wisdom I could never hope to attain, but one day I realized I was very wrong.

When comparing mindfulness activities with physical exercise and no exercise to treat cancer-related cognitive impairment, breast cancer survivors showed similar outcomes across the board, leading researchers to suggest acknowledging the side effect may help patients cope.

Losing my breasts was hard, but losing one of my best friends was even harder, and something I’ve had to come to terms with.

My cancer was caught early, and I never had to have chemotherapy — leading me experience survivor’s guilt and ask, “can I even call myself a survivor?”